The years 2022 and 2023 witnessed one of the most sensational legal dramas in recent Sri Lankan history. Night after night, television screens carried images from the Maligakanda Magistrate’s Court where senior officials of the Ministry of Health, alongside the then Minister of Health Keheliya Rambukwella, were escorted into court amid allegations surrounding the procurement of allegedly substandard medicines.
For many Sri Lankans, it was unprecedented. Senior administrators who had collectively served the State for more than 250 years were suddenly portrayed as central figures in a scandal involving life-saving medicines, public funds, and patient safety. The courtroom proceedings, driven largely by dramatic submissions made by the Deputy Solicitor General, became headline material across television channels and newspapers.
The allegations themselves were grave. Prosecutors alleged that amid the country’s crippling economic crisis and severe foreign exchange shortage, normal procurement procedures had been bypassed, resulting in the importation of allegedly substandard Human Immunoglobulin and Rituximab stocks.
However, as the matter has now moved before the Colombo High Court Trial-at-Bar, the atmosphere has changed significantly.
A different Courtroom environment
Unlike the emotionally charged proceedings before the Magistrate’s Court, the Trial-at-Bar has unfolded under the stricter evidentiary standards of the High Court. Proceedings now continue on a near day-to-day basis from 10 a.m. to 4 p.m., with witnesses subjected to lengthy examination and cross-examination.
The prosecution’s burden is no longer merely to raise suspicion. It must establish criminal liability beyond reasonable doubt.
What has emerged through testimony over the past several months is a far more complex picture of the conditions prevailing during Sri Lanka’s worst economic collapse since independence.
Witnesses have repeatedly described:
severe shortages of foreign exchange,
urgent medicine shortages in hospitals,
mounting public pressure on the health system,
delays in Letters of Credit,
collapsing procurement timelines,
and extraordinary administrative difficulties within the Ministry of Health.
Several officials who testified before the court have reportedly maintained that procedures were followed within the emergency framework that existed at the time. Documents, procurement papers, approvals, technical evaluation reports, and committee decisions have all been produced in court as part of the defence narrative.
The defence position appears increasingly focused on one central question:
If a successful bidder later supplied a substandard product, does criminal responsibility automatically fall upon the procurement committees and administrative officers who approved the purchase?
That question now lies at the heart of the Trial-at-Bar.
Proving the existence of substandard medicine alone is insufficient for criminal conviction. The prosecution must still prove criminal intent, conspiracy, or knowing misconduct by each accused individually. This is where the High Court Trial-at-Bar differs fundamentally from the earlier public narrative. Interestingly, the Trial-at-Bar has also reopened broader national discussions about due process and the presumption of innocence
The procurement dilemma
Public procurement in the health sector is a highly regulated process involving multiple layers of technical evaluation, financial clearance, recommendation, approval, and post-procurement quality checks.
Defence lawyers have argued that procurement committees do not themselves manufacture medicines, nor do they possess laboratory facilities to independently test pharmaceutical products before emergency procurement decisions are made.
They contend that unless evidence emerges showing deliberate manipulation, collusion, kickbacks, or intentional deviation to favour a particular supplier, criminal liability becomes difficult to establish merely because a product later failed quality standards.
This distinction has become increasingly important during the High Court proceedings.
Observers note that the prosecution’s task appears considerably more difficult than during the Magistrate’s Court phase, where public attention was driven largely by the dramatic nature of the allegations and arrests.
Comparison with other procurement controversies
The debate has inevitably drawn comparisons with other public procurement controversies, including the recent controversy over allegedly substandard coal supplies to the power sector.
In that matter, public criticism centred on whether procurement specifications had been manipulated to favour a particular supplier.
Yet in the ongoing medicine case, legal observers point out that no clear evidence has yet emerged publicly in the High Court proceedings showing that procurement committees intentionally engineered the system to select a fraudulent supplier.
Instead, much of the testimony appears to revolve around emergency decision-making during a period of national crisis.
Sri Lanka in 2022 was not functioning under normal economic conditions. Hospitals were facing shortages of essential drugs. Patients struggled to access life-saving medicines. Public pressure on health authorities intensified daily.
Against this backdrop, the defence argues that officials were attempting to maintain continuity of public health services under impossible circumstances.
The prosecution’s challenge
Deputy Solicitor General Lakmini Girihagama, who leads the prosecution, has consistently maintained that the procurement process was unlawfully manipulated and that public funds amounting to over Rs. 144 million were fraudulently misused.
The prosecution has also relied heavily on laboratory findings that allegedly identified bacterial contamination in Human Immunoglobulin stocks and saline solution in place of active cancer medication.
These allegations generated widespread public outrage when first revealed.
Yet legal analysts note that proving the existence of substandard medicine alone is insufficient for criminal conviction. The prosecution must still prove criminal intent, conspiracy, or knowing misconduct by each accused individually.
This is where the High Court Trial-at-Bar differs fundamentally from the earlier public narrative.
Presumption of innocence returns to the forefront
Interestingly, the Trial-at-Bar has also reopened broader national discussions about due process and the presumption of innocence.
Defence counsel appearing for several accused have repeatedly reminded court that every accused person is entitled to a fair trial regardless of public opinion or media narratives.
This argument appears to resonate increasingly as proceedings move away from sensational headlines and toward technical scrutiny of procurement regulations, administrative circulars, emergency approvals, and committee procedures.
Some legal commentators now suggest that the case may ultimately redefine how criminal liability is assessed in large-scale public procurement decisions made during national emergencies.
The substandard medicine case has already evolved into something much larger than the fate of a few officials.
It has exposed:
weaknesses in Sri Lanka’s pharmaceutical regulatory mechanisms,
vulnerabilities in emergency procurement systems,
the consequences of economic collapse on public healthcare,
and the tension between administrative decision-making and criminal accountability
A trial beyond individuals
Whatever the final outcome, the substandard medicine case has already evolved into something much larger than the fate of a few officials.
It has exposed:
weaknesses in Sri Lanka’s pharmaceutical regulatory mechanisms,
vulnerabilities in emergency procurement systems,
the consequences of economic collapse on public healthcare,
and the tension between administrative decision-making and criminal accountability.
The Trial-at-Bar is therefore not merely judging individuals. It is, in many ways, placing Sri Lanka’s entire crisis-era governance structure under legal examination.
And as witnesses continue to testify day after day before the three-judge bench, one reality is becoming increasingly clear:
The dramatic narrative that dominated the Magistrate’s Court may not necessarily translate easily into criminal convictions before the High Court.